Effect of chemotherapy on initial compressive osseointegration of tumor endoprostheses

Clinical Orthopaedics and Related Research

Volumn 459, Issue , 2007, Pages 48-53

  Avedian, R S ^a   Goldsby, R E ^b   Kramer, M J ^a   O'Donnell, R J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; ANTINEOPLASTIC AGENT;

ADULT; BODY MASS; BONE GROWTH; BONE PROSTHESIS; BONE REGENERATION; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENDOPROSTHESIS; EWING SARCOMA; FEMALE; FEMUR; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; PLASTIC SURGERY; PRIORITY JOURNAL; SIDE EFFECT; ARTICLE; BONE SCREW; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMUR TUMOR; FOLLOW UP; IMPLANTATION; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTHESIS FAILURE; SARCOMA; WEIGHT BEARING;

ADULT; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; FEMORAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; INTERNAL FIXATORS; MALE; OSSEOINTEGRATION; PROSTHESIS FAILURE; PROSTHESIS IMPLANTATION; SARCOMA; WEIGHT-BEARING;

EID: 34249945330     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e3180514c66     Document Type: Conference Paper

References (32)

1. Arikoski P, Komulainen J, Riikonen P, Parviainen M, Jurvelin JS, Voutilainen R, Kröger H. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer. J Bone Min Res. 1999;14:2002-2009.
2. Arikoski P, Komulainen J, Riikonen P, Voutilainen R, Knip M, Kröger H. Alterations in bone turnover and impaired development of bone mineral density in newly diagnosed children with cancer: a 1-year prospective study. J Clin Endocrinol Metab. 1999;84: 3174-3181.
3. Bath LE, Crofton PM, Evans AEM, Ranke MB, Elmlinger MW, Kelnar CJH, Wallace WHB. Bone turnover and growth during and after chemotherapy in children with solid tumors. Pediatr Res. 2004;55:224-230.
4. Bhangu AA, Kramer MJ, Grimer RJ, O'Donnell RJ. Early distal femoral endoprosthetic survival: cemented stems versus the Compress® implant. Internat Orthop. 2006;30:465-472.
5. Bickels J, Wittig JC, Kollender Y, Henshaw RM, Kellar-Graney KL, Meller I, Malawer M. Distal femoral resection with endoprosthetic reconstruction: a long-term followup study. Clin Orthop Relat Res. 2002;400:225-235.
6. Bini SA, Johnston JO, Martin DL. Compliant prestress fixation in tumor prostheses: interface retrieval data. Orthopedics. 2000;23:707-712.
7. Burchardt H, Glowczewskie FP, Enneking WF. The effect of adriamycin and methotrexate on the repair of segmental cortical autografts in dogs. J Bone Joint Surg Am. 1983;65:103-108.
8. Cristofolini L, Bini SA, Toni A. In vitro testing of a novel limb salvage prosthesis for the distal femur. Clinical Biomechan. 1998;13:608-615.
9. Dayer R, Rizzoli R, Kaelin A, Ammann P. Low protein intake is associated with impaired titanium implant osseointegration. J Bone Min Res. 2006;21:258-264.
10. Freedman EL, Eckardt JJ. A modular endoprosthetic system for tumor and non-tumor reconstruction: preliminary experience. Orthopedics. 1997;20:27-36.
11. Friedlander GE, Tross RB, Doganis AC, Kirkwood JM, Baron R. Effects of chemotherapeutic agents on bone: I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am. 1984;66:602-607.
12. Hazan EJ, Hornicek FJ, Tomford W, Gebhardt MC, Mankin HJ. The effect of adjuvant chemotherapy on osteoarticular allografts. Clin Orthop Relat Res. 2001;285:176-181.
13. Henshaw RM, Bickels J, Malawer MM. Modular endoprosthetic reconstruction for lower extremity skeletal defects: oncologic and reconstructive indications. Semin Arthroplasty. 1999;10:180-187.
14. Hornicek FJ, Gebhardt MC, Tomford WW, Sorger JI, Zavatta M, Menzner JP, Mankin HJ. Factors affecting nonunion of the allograft-host junction. Clin Orthop Relat Res. 2001;382:87-98.
15. Horowitz SM, Glasser DB, Lane JM, Healey JH. Prosthetic and extremity survivorship after limb salvage for sarcoma: how long do the reconstructions last? Clin Orthop Relat Res. 1993;293:280-286.
16. Kawai A, Healey JH, Boland PJ, Athanasian EA, Jeon D-G. A rotating hinge knee replacement for malignant tumors of the femur and tibia. J Arthroplasty. 1999;14:187-196.
17. Kawai A, Muschler GF, Lane JM, Otis JC, Healey JH. Prosthetic knee replacement after resection of a malignant tumor of the distal part of the femur. J Bone Joint Surg Am. 1998;80:636-647.
18. Kneisl JS, Finn HA, Simon MA. Mobile knee reconstructions after resection of malignant tumors of the distal femur. Orthop Clin North Am. 1991;22:105-119.
19. Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of highgrade bone sarcomas. J Bone Joint Surg Am. 1995;77:1154-1165.
20. Mittermayer F, Krepler P, Dominkus M, Schwameis E, Sluga M, Heinzl H, Kotz R. Long-term followup of uncemented tumor endoprostheses for the lower extremity. Clin Orthop Relat Res. 2001;388:167-177.
21. Mittermayer F, Windhager R, Dominkus M, Krepler P, Schwameis E, Sluga M, Kotz R, Strasser G. Revision of the Kotz type of tumour endoprosthesis for the lower limb. J Bone Joint Surg Br. 2002;84:401-406.
22. Safran MR, Kody MH, Namba RS, Larson KR, Kabo JM, Dorey FJ, Eilber FR, Eckardt JJ. 151 endoprosthetic reconstructions for patients with primary tumors involving bone. Contemp Orthop. 1994;29:15-25.
23. Shih L-Y, Sim FH, Pritchard DJ, Rock MG, Chao EYS. Segmental total knee arthroplasty after distal femoral resection for tumor. Clin Orthop Relat Res. 1993;292:269-281.
24. Sim FH, Beauchamp CP, Chao EYS. Reconstruction of musculoskeletal defects about the knee for tumor. Clin Orthop Relat Res. 1987;221:188-201.
25. Torbert JT, Fox EJ, Hosalkar HS, Ogilvie CM, Lackman RD. Endoprosthetic reconstructions: results of long-term followup of 139 patients. Clin Orthop Relat Res. 2005;438:51-59.
26. Unwin PS, Cannon SR, Grimer RJ, Kemp HBS, Sneath RS, Walker PS. Aseptic loosening in cemented custom-made prosthetic replacements for bone tumours of the lower limb. J Bone Joint Surg Br. 1996;78:5-13.
27. Unwin PS, Cobb JP, Walker PS. Distal femoral arthroplasty using custom-made prostheses: the first 218 cases. J Arthroplasty. 1993;8:259-268.
28. van Leeuwen BL, Kamps WA, Jansen HWB, Hoekstra HJ. The effect of chemotherapy on the growing skeleton. Cancer Treat Rev. 2000;26:363-376.
29. Ward WG, Eckardt JJ, Johnston-Jones KS, Eilber FR, Namba R, Dorey FJ, Mirra J, Kabo JM. Five to ten year results of custom endoprosthetic replacement for tumors of the distal femur. In: Brown KLB, ed. Complications of Limb Salvage: Prevention, Management and Outcomes. Montreal: International Society of Limb Salvage; 1991:483-491.
30. Ward WG Sr, Dorey F, Kelly C, Kabo JM, Wirganowicz PZ, Eckardt JJ. Lessons from massive tumor endoprostheses: implications for future tumor and total joint endoprostheses. Semin Arthroplasty. 1999;10:124-132.
31. Yasko AW, Lin PP, Weber KL. Survivorship of segmental prosthetic arthroplasty for limb salvage following bone sarcoma resections. Sarcoma. 2001;5:61-62.
32. Zart DJ, Miya DA, Makley JT, Stevenson S. The effects of cisplatin on the incorporation of fresh syngeneic and frozen allogeneic cortical bone grafts. J Orthop Res. 1993;11:240-249.